1. |
Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China:a large population-based survey. Am J Respir Crit Care Med, 2007, 176(8):753-760.
|
2. |
Loganathan RS, Stover DE, Shi W, et al. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest, 2006, 129(5):1305-1312.
|
3. |
Benzo R, Kelley GA, Recchi L, et al. Complications of lung resection and exercise capacity:a meta-analysis. Respir Med, 2007, 101(8):1790-1797.
|
4. |
支修益. 胸外科围手术期气道管理专家共识(2012 年版).中国胸心血管外科临床杂志, 2013, 20(3):251-255.
|
5. |
杨为贵, 杨春, 聂文双, 等. 肺功能不全食管癌患者的围手术期处理. 中国胸心血管外科临床杂志, 2011, 18(3):273-275.
|
6. |
全志伟. 肺功能测定对腹部手术风险及术后并发症的评估作用. 中国实用外科杂志, 2004, 24(3):142-144.
|
7. |
Wong DH, Weber EC, Schell MJ, et al. Factors associated with postoperative pulmonary complications in patients with severe chronic obstructive pulmonary disease. Anesth Analg, 1995, 80(2):276-284.
|
8. |
崔玉尚, 张志庸, 阿伊都·阿布都热伊木. 开胸术后早期肺功能的变化规律及影响因素分析. 中华外科杂志, 2003, 41(12):909-912.
|
9. |
Miyoshi S, Yoshimasu T, Hirai T, et al. Exercise capacity of thoracotomy patients in the early postoperative period. Chest, 2000, 118(2):384-390.
|
10. |
矫文捷, 王天佑, 龚民, 等. 非小细胞肺癌并COPD患者术后肺部并发症分析. 中华临床医药杂志, 2004, 5(2):15-17.
|
11. |
俞婷婷, 谢德荣, 杜黎明, 等. 普米克令舒联合可必特雾化吸入改善肺癌合并重度COPD患者术前肺功能及扩大手术适应症研究. 临床肺科杂志, 2013, 18(5):793-795.
|
12. |
唐建新, 张贻秋, 向志, 等. 长期吸入糖皮质激素联合异丙托溴铵治疗COPD疗效观察. 临床肺科杂志, 2008, 13(1):86.
|
13. |
杨鲁民, 矫文捷, 陈岩, 等. 中重度慢性阻塞性肺疾病合并肺癌围手术期肺功能的保护. 中国肿瘤外科杂志, 2012, 4(2):67-71.
|
14. |
中华医学会儿科学分会呼吸学组《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南. 中华儿科杂志, 2008, 46(10):745-753.
|
15. |
柳涛, 蔡柏蔷. 慢性阻塞性肺疾病诊断、处理和预防全球策略(2011 年修订版)介绍. 中国呼吸与危重监护杂志, 2012, 11(1):1-12.
|
16. |
王天佑. 胸外科围手术期肺保护的专家共识. 中华外科杂志, 2009, 47(18):1361-1364.
|
17. |
W ilson S J, Wallin A, Sand strom T, et al. Effect of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. Am J Respir Critare Med, 2001, 164(6):1047-1052.
|
18. |
Koizumi K, Haraguchi S, Hirata T, et al. Surgery treatment for lung cancer patients with poor pulmonary function. Ann Thorac Cardiovasc, 2005, 11(2):87-92.
|
19. |
Mei J, Liu LX, Tang ML, et al. Airway bacterial colonization in patients with non-small cell lung cancer and the alterations during the perioperative period. J Thorac Disease, 2014, 6(9):2072-1439.
|
20. |
Stetinova V, Herout V, Kvetina J. In vitro and in vivo antioxidant activity of ambroxol. Clin Exp Med, 2004, 4(3):152-158.
|
21. |
Beeh KM, Beier J, Esperester A, et al. Antiinflammatory properties of ambroxol. Eur J Med Res, 2008, 13(12):557-562.
|
22. |
张国清, 朱光发. 大剂量沐舒坦防治呼吸窘迫综合征的研究进展. 国外医学:呼吸系统分册, 2003, 23(2):76-78.
|
23. |
Wunderer H, Morgenroth K, Weis G. The cleaning system of the airways:physiology, pathophysiology and effects of ambroxol. Med Monatsschr Pharm, 2009, 32(2):42-47.
|
24. |
Refai M, Brunelli A, Xiumé F, et al. Short-term perioperative treatment with ambroxol reduces pulmonary complications and hospital costs after pulmonary lobectomy:a randomized trial. Eur J Cardiothorac Surg, 2009, 35(3):469-473.
|
25. |
支修益. 加强胸外科围手术期气道管理, 降低肺癌合并慢性阻塞性肺病患者并发症. 中国胸心血管外科临床杂志, 2014, 21(5):575-576.
|